Patents by Inventor Reinhard Paschke

Reinhard Paschke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for inhibiting tumor growth
    Patent number: 7851462
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: December 14, 2010
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • METHODS AND COMPOSITIONS FOR INHIBITING TUMOR GROWTH
    Publication number: 20080214516
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Application
    Filed: December 21, 2007
    Publication date: September 4, 2008
    Applicant: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Methods and compositions for inhibiting tumor growth
    Patent number: 7312205
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Grant
    Filed: February 11, 2004
    Date of Patent: December 25, 2007
    Assignee: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Medicament for inhibiting tumour growth
    Publication number: 20060194774
    Abstract: The present invention relates to novel betulinic acid derivatives with increased activity for the treatment of carcinomas and HIV diseases, a method for preparing such novel betulinic acid derivatives as well as their use as pharmaceuticals.
    Type: Application
    Filed: February 11, 2004
    Publication date: August 31, 2006
    Applicant: Novelix Pharmaceuticals, Inc.
    Inventors: Edgar Selzer, Burkhard Jansen, Reinhard Paschke
  • Mixture containing rare earth and the use thereof
    Publication number: 20030012325
    Abstract: A thulium oxide-containing mixture consisting of a matrix material in which the thulium oxide is homogeneously distributed and forms therewith a body, which can be radioactivated by exposure to neutron radiation.
    Type: Application
    Filed: April 19, 2002
    Publication date: January 16, 2003
    Inventors: Norbert Kernert, Klaus Schlosser, Wolfgang Fleig, Joachim Lesske, Martin Luckner, Matthias Brandsch, Gerd Hause, Reinhard Paschke, Manfred Arnold, Willy Frank
  • Ferroelectric liquid crystals
    Patent number: 4874544
    Abstract: Fast-switching displays with memory properties are provided, which can display digits, symbols, and images, and which contain as chemically and thermally stable ferroelectric liquid crystalline substances, according to the invention, liquid crystalline derivatives which contain a chiral alkyl halide residue corresponding to the general formula ##STR1## are used in mixtures of one another as well as in conjunction with other liquid crystalline or non-crystalline liquid substances.
    Type: Grant
    Filed: February 3, 1988
    Date of Patent: October 17, 1989
    Assignee: VEB Werk fuer Fernsehelektronik im VEB Kombinat Mikroelektronik
    Inventors: Bak G. Yong, Barth Petra, Demus Dietrich, Joachimi Detlev, Barbara Kampa, Saskia Kohler, Kristine Mohr, Reinhard Paschke, Gerhard Pelzl, Ulrich Rosenfeld, Wolfgang Schafer, Klaus-Dieter Scherf, Carsten Tschirske, Wolfgang Weissflog, Horst Zaschke
  • Liquid crystalline substances
    Patent number: 4668426
    Abstract: Nematic liquid crystalline substances as additives in mixtures for electro-optical systems for the rendition of numbers, symbols and images. The additives provide new liquid crystalline substances of broad mesophase ranges which improve the chemical stability of the substance mixtures. It has been found that liquid crystalline 5-alkyl-pyridine-2-carboxylic acid esters of the general formula ##STR1## are suitable for utilization in mixtures for electro-optical displays for the rendition of numbers, symbols and images.
    Type: Grant
    Filed: March 29, 1985
    Date of Patent: May 26, 1987
    Assignee: VEB Werk f/u/ r Fernsehelektronik im VEB Kombinat Mikroelektronik
    Inventors: Dietrich Demus, Horst Zaschke, Reinhard Paschke, Adalbert Wiegeleben